Patho.ai provides a cloud‑native AI platform that speeds up molecular targeting in drug discovery by using Gemini‑powered generative models and a Neo4j graph knowledge base to design novel compounds and navigate biochemical relationships. It offers real‑time 3D rendering of protein‑ligand interactions and virtual high‑throughput screening of millions of binding configurations, eliminating early‑stage synthesis costs and enabling rapid iteration for pharma, biotech, and academic researchers.
Funding
Funding not disclosed
Founders
Product
Problem
Drug discovery teams face lengthy and costly cycles due to slow target validation, limited ability to explore vast chemical spaces, and reliance on expensive wet‑lab synthesis for binding assays.
Solution
Patho.ai offers a cloud‑native AI platform that accelerates molecular targeting across the entire discovery workflow. The system combines Gemini‑powered generative models with a Neo4j graph knowledge base to propose novel compounds and navigate complex biochemical relationships. Real‑time 3D rendering and hardware‑accelerated Three.js visualization let users inspect predicted protein‑ligand interactions at the atomic level. Virtual high‑throughput screening evaluates binding affinities for millions of configurations in the cloud, eliminating the need for physical synthesis during early stages. A $0 compute tier provides cost‑free scaling, enabling researchers to iterate rapidly and prioritize the most promising candidates for experimental validation.
Target Audience
Primary customers are pharmaceutical R&D departments, biotech companies, and academic research groups that need rapid, computationally efficient tools for target identification, compound design, and early‑stage binding assessment.
Features
- Gemini generative AI for de‑novo molecule design tailored to specific targets
- Neo4j graph architecture that integrates pathways, literature, and molecular relationships for knowledge‑driven discovery
- Cloud‑based virtual high‑throughput screening of binding affinities across millions of configurations
- Real‑time, hardware‑accelerated 3D rendering of full PDB structures with interactive atom‑level manipulation
- Visual validation tools that overlay AI predictions onto structural models for immediate assessment
- $0 compute tier allowing unlimited scaling without upfront infrastructure costs